ID :
113227
Wed, 03/24/2010 - 08:58
Auther :
Shortlink :
https://oananews.org//node/113227
The shortlink copeid
GOVT IMPLEMENTING DOTS PLUS TO OVERCOME DRUG-RESISTANT TB GERMS
Jakarta, March 23 (ANTARA) - The Indonesian government is implementing a Directly Observed Treatment Short Course Strategy (DOTS) Plus to prevent the resistance of germs which caused tuberculosis to anti-tuberculosis drugs.
The Health Ministry`s secretary general, Ratna Rosita Hendardji, said the strategy - also called the Programmatic Management of Drug Resistant TB (PMDT) - is expected to control TB transmission with Multi Drug Resistant TB ( MDR-TB).
Speaking at the opening of seminar on tuberculosis here Tuesday, she said MDR-TB is caused by tuberculosis Mycobacterium that has become immune to two anti-tuberculosis drugs, namely Ioniazid or INH and Rrifampicin together or with the first line anti-TB drugs such as Ethambutol, Streptomycin and Pirazinamide.
"In Indonesia, MDR-TB cases among new patients are estimated at 1.6 percent of TB patients who have undergone 16 percent of the medication," Ratna said in reading out Health Minister Endang Rahayu Sedyaningsih`s speech.
The number of MDR-TB patients in Indonesia according to 2007 Health Ministry data was as many as 6,395 MDR-TB cases of 12,209 cases per year.
According to Ratna, the MDR-TB treatment was very difficult and expensive, therefore the government called on all parties involved in efforts to prevent MDR-TB with DOTS Plus strategy.
DOTS Plus strategy consists of five components, namely sustained political commitment in mobilizing resources for dealing with MDR-TB, diagnosis and quality through a culture test to detect the intensity drug cases, took the drug control directly with second-line anti-TB drugs, continually anti-TB drugs provision, and the recording and reporting system on the program`s implementation.
The government is providing anti-TB second-line treatment required in MDR-TB. "Besides, the TB Green Light `has agreed to treat 100 MDR-TB patients in DOTS Plus pilot project in East Jakarta and Surabaya," she said.
Further, the Director of Directly Transmitted Disease Control from the Health Ministry, Iwan M Muljono, said the DOTS Plus application strategy had been tested at the Persahabatan Hospital in East Jakarta and Dr. Sutomo Hospital in Surabaya on October 12, 2009.
The DOTS Plus implementation experimental data collected until March 11, 2010 shows the number of patients who were suspected of MDR-TB are as many as 241 patients, patients with MDR-TB confirmed by testing the drug density are 69 people and 34 treated patients.
Implementation of DOTS Plus strategy, will be extended to two areas in Jakarta and six districts around Surabaya in 2010, according to Iwan.
"It is also planned to open new areas in the provinces of West Java, Central Java, Yogyakarta and South Sulawesi," he said.
The Health Ministry`s secretary general, Ratna Rosita Hendardji, said the strategy - also called the Programmatic Management of Drug Resistant TB (PMDT) - is expected to control TB transmission with Multi Drug Resistant TB ( MDR-TB).
Speaking at the opening of seminar on tuberculosis here Tuesday, she said MDR-TB is caused by tuberculosis Mycobacterium that has become immune to two anti-tuberculosis drugs, namely Ioniazid or INH and Rrifampicin together or with the first line anti-TB drugs such as Ethambutol, Streptomycin and Pirazinamide.
"In Indonesia, MDR-TB cases among new patients are estimated at 1.6 percent of TB patients who have undergone 16 percent of the medication," Ratna said in reading out Health Minister Endang Rahayu Sedyaningsih`s speech.
The number of MDR-TB patients in Indonesia according to 2007 Health Ministry data was as many as 6,395 MDR-TB cases of 12,209 cases per year.
According to Ratna, the MDR-TB treatment was very difficult and expensive, therefore the government called on all parties involved in efforts to prevent MDR-TB with DOTS Plus strategy.
DOTS Plus strategy consists of five components, namely sustained political commitment in mobilizing resources for dealing with MDR-TB, diagnosis and quality through a culture test to detect the intensity drug cases, took the drug control directly with second-line anti-TB drugs, continually anti-TB drugs provision, and the recording and reporting system on the program`s implementation.
The government is providing anti-TB second-line treatment required in MDR-TB. "Besides, the TB Green Light `has agreed to treat 100 MDR-TB patients in DOTS Plus pilot project in East Jakarta and Surabaya," she said.
Further, the Director of Directly Transmitted Disease Control from the Health Ministry, Iwan M Muljono, said the DOTS Plus application strategy had been tested at the Persahabatan Hospital in East Jakarta and Dr. Sutomo Hospital in Surabaya on October 12, 2009.
The DOTS Plus implementation experimental data collected until March 11, 2010 shows the number of patients who were suspected of MDR-TB are as many as 241 patients, patients with MDR-TB confirmed by testing the drug density are 69 people and 34 treated patients.
Implementation of DOTS Plus strategy, will be extended to two areas in Jakarta and six districts around Surabaya in 2010, according to Iwan.
"It is also planned to open new areas in the provinces of West Java, Central Java, Yogyakarta and South Sulawesi," he said.
